Vaiomer is happy to announce that we will take part in the 4th edition of « Journées Polepharma De Microbiomique » on...
Highlights Articles
Vaiomer is taking part to « 7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du CALM»
Vaiomer is happy to announce its participation to "7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du Club Alzheimer de...
Vaiomer is participating in the Genotoul Scientific Day-HOLOBIONTES
Vaiomer is happy to announce that we will be participating in the “Genotoul Scientific Day: HOLOBIONTES Understanding...
Probiotic strains translocate to the tumor and improve ICI efficacy through indole-3-aldehyde release
DOI: 10.1016/j.cell.2023.03.011In recent years, several studies have shown the importance of both the gut and the...
The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi
DOI N°1: 10.1126/science.aay9189DOI N° 2: 10.1016/j.cell.2022.09.005Several studies have shown the importance of the...
Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity
doi: 10.21037/atm-20-6427Immunotherapy has revolutionized the treatment of several cancers. However, it remains...
Meet Vaiomer at the AFSSI Connexions 2023 – Montpellier
Vaiomer is participating in «la 10e édition des AFSSI Connexions» on July 04 and 05 in MontpellierVaiomer’s...
Resistance to anti-PD-1 immunotherapy can be attributed to the gut microbiome
DOI: 10.1126/science.aan4236 DOI: 10.1126/science.aao3290 DOI: 10.1126/science.aan370Immunotherapies (Immune...
Vaiomer is taking part to « la deuxième édition de LA JOURNÉE DU MICROBIOTE»
Vaiomer is happy to announce its participation to "la deuxième édition de la journée microbiote de MetaGenopolis" on...